Post-Operative Treatment With Ketorolac After Abdominal Myomectomy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00845754 |
Recruitment Status :
Completed
First Posted : February 18, 2009
Last Update Posted : February 18, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Febrile Morbidity Pain | Drug: ketorolac Drug: saline | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 112 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double (Participant, Care Provider) |
Primary Purpose: | Treatment |
Official Title: | Effects of Ketorolac on Post-Operative Febrile Morbidity and Pain Management in Abdominal Myomectomy Patients |
Study Start Date : | September 1999 |
Actual Primary Completion Date : | August 2001 |
Actual Study Completion Date : | August 2001 |

Arm | Intervention/treatment |
---|---|
Placebo Comparator: 1
Placebo
|
Drug: saline
15mg IV every 6hrs for 4 doses |
Active Comparator: 2
Ketorolac
|
Drug: ketorolac
15mg IV every6 hours for 4doses
Other Name: Toradol |
- Post-operative febrile morbidity [ Time Frame: Inital 24hrs post-operative ]
- Post-operative pain management [ Time Frame: Initial 24hrs post-operative ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Ant patient undregoing abdominal myomectomy
Exclusion Criteria:
- Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00845754
United States, New York | |
Columbia University Medical Center | |
New York, New York, United States, 10032 |
Responsible Party: | Charles Ascher-Walsh MD, Mount Sinai School of Medicine |
ClinicalTrials.gov Identifier: | NCT00845754 |
Other Study ID Numbers: |
ASW 124 |
First Posted: | February 18, 2009 Key Record Dates |
Last Update Posted: | February 18, 2009 |
Last Verified: | February 2009 |
Post-operative febrile morbidity Post-operative pain management |
Fever Body Temperature Changes Ketorolac Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents |
Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |